Chemoinformaics analysis of Sym-homospermidine
| Molecular Weight | 159.277 | nRot | 8 |
| Heavy Atom Molecular Weight | 138.109 | nRig | 0 |
| Exact Molecular Weight | 159.174 | nRing | 0 |
| Solubility: LogS | 0.878 | nHRing | 0 |
| Solubility: LogP | -0.682 | No. of Aliphatic Rings | 0 |
| Acid Count | 0 | No. of Aromatic Rings | 0 |
| Base Count | 3 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 32 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 11 | No. of Aromatic Carbocycles | 0 |
| nHetero | 3 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 21 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 8 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 3 | No. of Arom Atom | 0 |
| No. of Oxygen atom | 0 | No. of Arom Bond | 0 |
| nHA | 3 | APOL | 30.6627 |
| nHD | 3 | BPOL | 20.4973 |
| QED | 0.439 |
| Synth | 2.063 |
| Natural Product Likeliness | 0.151 |
| NR-PPAR-gamma | 0.003 |
| Lipinski | Accepted |
| Pfizer | Accepted |
| GSK | Accepted |
| Golden Triangle | Rejected |
| Pgp-inh | 0.447 |
| Pgp-sub | 0.971 |
| HIA | 0.164 |
| CACO-2 | -6.258 |
| MDCK | 0.00000625 |
| BBB | 0.181 |
| PPB | 0.213556 |
| VDSS | 0.94 |
| FU | 0.925836 |
| CYP1A2-inh | 0.013 |
| CYP1A2-sub | 0.058 |
| CYP2c19-inh | 0.016 |
| CYP2c19-sub | 0.241 |
| CYP2c9-inh | 0.001 |
| CYP2c9-sub | 0.05 |
| CYP2d6-inh | 0.006 |
| CYP2d6-sub | 0.899 |
| CYP3a4-inh | 0.006 |
| CYP3a4-sub | 0.234 |
| CL | 6.521 |
| T12 | 0.285 |
| hERG | 0.061 |
| Ames | 0.029 |
| ROA | 0.553 |
| SkinSen | 0.945 |
| Carcinogencity | 0.022 |
| EI | 0.073 |
| Respiratory | 0.819 |
| NR-Aromatase | 0.009 |
| Antiviral | No |
| Prediction | 0.877139 |